BioWorld-International-2010-03-10
Cellzome Lands Big GSK Deal: 475M for Inflammatory Diseases
Cellzome Lands Big GSK Deal: €475M for Inflammatory Diseases
LONDON – Cellzome Ltd. signed its second big deal with GlaxoSmithKline plc, agreeing on a €475 million (US$644.3 million) collaboration to apply its epigenetics platform technology in the discovery of oral small-molecule drugs for treating immuno-inflammatory diseases. (BioWorld International)
BioWorld International Correspondent

